A predictive nomogram for EGFR mutation status in lung adenocarcinoma manifesting as ground-glass nodules.

IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2024-11-30 Epub Date: 2024-11-18 DOI:10.21037/jtd-24-1166
Xiaoxia Ping, Qian Meng, Nan Jiang, Su Hu
{"title":"A predictive nomogram for <i>EGFR</i> mutation status in lung adenocarcinoma manifesting as ground-glass nodules.","authors":"Xiaoxia Ping, Qian Meng, Nan Jiang, Su Hu","doi":"10.21037/jtd-24-1166","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The mutation status of epidermal growth factor receptor (<i>EGFR</i>) in lung adenocarcinoma is significantly associated with postoperative progression-free survival. Computed tomography (CT)-based radiomics analysis may have potential value in predicting <i>EGFR</i> mutation status. This study aims to explore the predictive capacity of radiomics analysis for <i>EGFR</i> mutation status in lung adenocarcinomas presenting as ground-glass nodules (GGNs).</p><p><strong>Methods: </strong>We included 199 GGNs confirmed by histopathology from 2016 to 2020. The clinical factors and radiographic characteristics were counted and evaluated. All GGNs were manually delineated and the radiomics features were extracted, using the least absolute shrinkage and selection operator for feature selection. Then the radiographic, radiomics, and combined nomogram model were constructed respectively, and compared with each other. Decision curve analysis (DCA) was used to assess the clinical usefulness of the models, while receiver operating characteristic curves and calibration curves were used to evaluate their predictive performance.</p><p><strong>Results: </strong>Univariate analysis revealed five variables that were significantly different between the <i>EGFR</i> mutant and wild-type groups. Fifteen radiomics features were significantly associated with <i>EGFR</i> mutations. Among the three models, both the radiomics [area under the curve (AUC) =0.818] and the nomogram (AUC =0.820) had good discriminatory ability in predicting <i>EGFR</i> mutation status and performed consistently in the validation cohort (AUC =0.805, and 0.833, respectively), with higher predictive performance than the radiographic model. The DCA showed that when it comes to <i>EGFR</i> mutation status prediction, the nomogram and the radiomics model showed better overall net benefit than the radiographic model.</p><p><strong>Conclusions: </strong>For preoperatively predicting the status of <i>EGFR</i> mutation in lung adenocarcinomas manifesting as GGNs, the CT-based radiomics analysis will be valuable.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7477-7489"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635277/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-1166","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The mutation status of epidermal growth factor receptor (EGFR) in lung adenocarcinoma is significantly associated with postoperative progression-free survival. Computed tomography (CT)-based radiomics analysis may have potential value in predicting EGFR mutation status. This study aims to explore the predictive capacity of radiomics analysis for EGFR mutation status in lung adenocarcinomas presenting as ground-glass nodules (GGNs).

Methods: We included 199 GGNs confirmed by histopathology from 2016 to 2020. The clinical factors and radiographic characteristics were counted and evaluated. All GGNs were manually delineated and the radiomics features were extracted, using the least absolute shrinkage and selection operator for feature selection. Then the radiographic, radiomics, and combined nomogram model were constructed respectively, and compared with each other. Decision curve analysis (DCA) was used to assess the clinical usefulness of the models, while receiver operating characteristic curves and calibration curves were used to evaluate their predictive performance.

Results: Univariate analysis revealed five variables that were significantly different between the EGFR mutant and wild-type groups. Fifteen radiomics features were significantly associated with EGFR mutations. Among the three models, both the radiomics [area under the curve (AUC) =0.818] and the nomogram (AUC =0.820) had good discriminatory ability in predicting EGFR mutation status and performed consistently in the validation cohort (AUC =0.805, and 0.833, respectively), with higher predictive performance than the radiographic model. The DCA showed that when it comes to EGFR mutation status prediction, the nomogram and the radiomics model showed better overall net benefit than the radiographic model.

Conclusions: For preoperatively predicting the status of EGFR mutation in lung adenocarcinomas manifesting as GGNs, the CT-based radiomics analysis will be valuable.

表现为磨玻璃结节的肺腺癌表皮生长因子受体突变状态的预测提名图。
背景:肺腺癌中表皮生长因子受体(EGFR)的突变状态与术后无进展生存期密切相关。基于计算机断层扫描(CT)的放射组学分析在预测表皮生长因子受体突变状态方面可能具有潜在价值。本研究旨在探索放射组学分析对表现为磨玻璃结节(GGNs)的肺腺癌的表皮生长因子受体突变状态的预测能力:我们纳入了2016年至2020年经组织病理学证实的199例GGN。统计并评估了临床因素和放射学特征。使用最小绝对收缩和选择算子进行特征选择,人工划定所有 GGN 并提取放射组学特征。然后分别构建了放射学模型、放射组学模型和组合提名图模型,并进行了比较。决策曲线分析(DCA)用于评估模型的临床实用性,接收者操作特征曲线和校准曲线用于评估模型的预测性能:单变量分析显示,表皮生长因子受体突变组和野生型组之间有五个变量存在显著差异。15个放射组学特征与表皮生长因子受体突变明显相关。在三种模型中,放射组学模型[曲线下面积(AUC)=0.818]和提名图(AUC=0.820)在预测表皮生长因子受体突变状态方面具有良好的鉴别能力,在验证队列中表现一致(AUC分别为0.805和0.833),预测性能高于放射学模型。DCA显示,在表皮生长因子受体突变状态预测方面,提名图和放射组学模型的总体净效益优于放射摄影模型:结论:对于术前预测表现为GGN的肺腺癌的表皮生长因子受体突变状态,基于CT的放射组学分析将很有价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信